Sarah Mackie

8.2k total citations
137 papers, 2.4k citations indexed

About

Sarah Mackie is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Sarah Mackie has authored 137 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Rheumatology, 71 papers in Pulmonary and Respiratory Medicine and 29 papers in Genetics. Recurrent topics in Sarah Mackie's work include Vasculitis and related conditions (70 papers), Otitis Media and Relapsing Polychondritis (31 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (25 papers). Sarah Mackie is often cited by papers focused on Vasculitis and related conditions (70 papers), Otitis Media and Relapsing Polychondritis (31 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (25 papers). Sarah Mackie collaborates with scholars based in United Kingdom, United States and Australia. Sarah Mackie's co-authors include Ann W Morgan, Colin Pease, E. Hensor, Bhaskar Dasgupta, Dennis McGonagle, Christian Mallen, Elisabeth Brouwer, James Robinson, Kornelis S. M. van der Geest and Paul Emery and has published in prestigious journals such as The Lancet, PLoS ONE and Cancer Research.

In The Last Decade

Sarah Mackie

125 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Mackie United Kingdom	27	1.1k	1.1k	513	475	243	137	2.4k
K.H. Ly France	31	1.2k 1.1×	1.3k 1.2×	376 0.7×	450 0.9×	96 0.4×	139	2.7k
Michel De Bandt France	28	1.3k 1.1×	595 0.5×	693 1.4×	310 0.7×	506 2.1×	81	2.7k
Michael Seitz Switzerland	24	1.0k 0.9×	663 0.6×	827 1.6×	242 0.5×	248 1.0×	62	2.4k
Gülen Hatemi Türkiye	31	1.8k 1.6×	1.7k 1.5×	433 0.8×	175 0.4×	482 2.0×	189	4.1k
Camilla Bengtsson Sweden	28	2.4k 2.1×	455 0.4×	592 1.2×	256 0.5×	409 1.7×	52	3.3k
Alvise Berti Italy	27	824 0.7×	1.1k 1.0×	601 1.2×	325 0.7×	111 0.5×	114	2.6k
Afzal Chaudhry United Kingdom	35	767 0.7×	1.2k 1.1×	1.1k 2.1×	469 1.0×	165 0.7×	68	3.5k
Corrado Campochiaro Italy	31	1.1k 0.9×	654 0.6×	511 1.0×	199 0.4×	194 0.8×	173	3.3k
J. Dixey United Kingdom	23	1.8k 1.5×	586 0.5×	301 0.6×	217 0.5×	541 2.2×	49	2.6k
J O'donnell New Zealand	27	731 0.6×	264 0.2×	380 0.7×	255 0.5×	255 1.0×	62	1.8k

Countries citing papers authored by Sarah Mackie

Since Specialization

Citations

This map shows the geographic impact of Sarah Mackie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Mackie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Mackie more than expected).

Fields of papers citing papers by Sarah Mackie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Mackie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Mackie. The network helps show where Sarah Mackie may publish in the future.

Co-authorship network of co-authors of Sarah Mackie

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Mackie. A scholar is included among the top collaborators of Sarah Mackie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Mackie. Sarah Mackie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cannatà, Antonio, Sarah Mackie, Miu Lam, et al.. (2025). Ethnic variations in neutrophil count as predictors of prognosis following acute myocardial infarction. Atherosclerosis. 403. 119169–119169. 1 indexed citations

Mackie, Sarah, Max Yates, & Kenneth J. Warrington. (2025). Polymyalgia rheumatica and giant cell arteritis: lumping versus splitting. Lara D. Veeken. 65(2).

Lax, S., Emma Dures, Vivien Lowndes, et al.. (2025). Patient perspectives on the impact of appearance and weight changes attributed to systemic glucocorticoid treatment of rheumatic diseases. Lara D. Veeken. 64(6). 3854–3862. 1 indexed citations

Marco, Gabriele De, Katya Meridor, Tom Macleod, et al.. (2025). Late‐Onset Spondyloarthritis Presenting as Glucocorticoid‐Resistant Polymyalgia Rheumatica: A Hitherto Underappreciated Entity in Which Tumor Necrosis Factor or Interleukin ‐17 Blockade May Have a Therapeutic Role. Arthritis & Rheumatology. 78(1). 131–140.

Tieu, Joanna, Kevin Yip, Nilasha Ghosh, et al.. (2024). Prioritising domains of glucocorticoid therapy to measure in trials: Results from a modified delphi exercise from the OMERACT glucocorticoid impact working group. Seminars in Arthritis and Rheumatism. 71. 152602–152602. 1 indexed citations

Zhao, Sizheng Steven, Sarah Mackie, Susanna C. Larsson, Stephen Burgess, & Shuai Yuan. (2024). Modifiable risk factors and inflammation-related proteins in polymyalgia rheumatica: genome-wide meta-analysis and Mendelian randomization. Lara D. Veeken. 64(5). 3012–3018. 3 indexed citations

Bukhari, Marwan, Bridget Griffiths, Shahir Hamdulay, et al.. (2023). Quality standards for the care of people with giant cell arteritis in secondary care. Lara D. Veeken. 62(9). 3075–3083. 3 indexed citations

Maunder, Daniel, Philip M. Brown, Dennis Lendrem, et al.. (2023). Micro-RNA content of circulating extracellular vesicles in early rheumatoid arthritis as biomarkers and mediators of methotrexate efficacy. Lara D. Veeken. 63(8). 2259–2267. 8 indexed citations

Owen, Claire, Max Yates, David Liew, et al.. (2023). Imaging of giant cell arteritis – recent advances. Best Practice & Research Clinical Rheumatology. 37(1). 101827–101827. 3 indexed citations

10.

Morgan, Ann W, et al.. (2023). Histopathology reporting of temporal artery biopsy specimens for giant cell arteritis: results of a modified Delphi study. Journal of Clinical Pathology. 77(7). 464–470. 6 indexed citations

11.

Bösch, Philipp, Milena Bond, Christian Dejaco, et al.. (2023). OP0188 IMAGING IN DIAGNOSIS, MONITORING AND OUTCOME PREDICTION OF LARGE VESSEL VASCULITIS: A SYSTEMATIC LITERATURE REVIEW INFORMING THE 2023 UPDATE OF THE EULAR RECOMMENDATIONS. Annals of the Rheumatic Diseases. 82. 124–125. 2 indexed citations

12.

Ndosi, Mwidimi, Jill Dawson, Patricia Richards, et al.. (2023). OP0280-HPR VALIDATION OF A NEW GLUCOCORTICOID-SPECIFIC PATIENT REPORTED OUTCOME QUESTIONNAIRE (THE STEROID PRO). Annals of the Rheumatic Diseases. 82. 184–184. 1 indexed citations

13.

Engamba, Serge, Emma Henderson, Claire Jones, et al.. (2023). Treatment of polymyalgia rheumatica: British Society for Rheumatology guideline scope. Rheumatology Advances in Practice. 8(1). rkae002–rkae002. 2 indexed citations

14.

Dures, Emma, et al.. (2023). Jaw claudication and jaw stiffness in giant cell arteritis: secondary analysis of a qualitative research dataset. Rheumatology Advances in Practice. 8(1). rkad082–rkad082. 3 indexed citations

15.

Taylor, John, Faye Elliott, E. O'Sullivan, et al.. (2023). Common co-morbidities in polymyalgia rheumatica and giant cell arteritis: cross-sectional study in UK Biobank. Rheumatology Advances in Practice. 7(3). rkad095–rkad095. 3 indexed citations

16.

Yip, Kevin, Vasilis S. Vasiliou, David A. Katz, et al.. (2023). Consensus of the definitions of the OMERACT glucocorticoid impact core domain set for people with rheumatic and musculoskeletal diseases. Seminars in Arthritis and Rheumatism. 64. 152338–152338. 1 indexed citations

17.

Zhao, Sizheng Steven, Yu Qian, Sarah Mackie, Chengping Wen, & Yingying Mao. (2021). Genetically predicted serum urate levels have no causal role on depression or other psychiatric disorders. Clinical Rheumatology. 40(9). 3729–3733. 5 indexed citations

18.

Yates, Max, Claire Owen, Sara Müller, et al.. (2020). Feasibility and Face Validity of Outcome Measures for Use in Future Studies of Polymyalgia Rheumatica: An OMERACT Study. The Journal of Rheumatology. 47(9). 1379–1384. 7 indexed citations

19.

Ehlers, Lisa, Johan Askling, Maurizio Cutolo, et al.. (2019). 2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis. Annals of the Rheumatic Diseases. 78(9). 1160–1166. 57 indexed citations

20.

Duarte, Cátia, et al.. (2015). Outcome Measures in Polymyalgia Rheumatica. A Systematic Review. The Journal of Rheumatology. 42(12). 2503–2511. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact